留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

《移植器官质量与安全指南(第6版)》解读——感染性疾病传播的风险

叶伯根 张雷

叶伯根, 张雷. 《移植器官质量与安全指南(第6版)》解读——感染性疾病传播的风险[J]. 器官移植, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016
引用本文: 叶伯根, 张雷. 《移植器官质量与安全指南(第6版)》解读——感染性疾病传播的风险[J]. 器官移植, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016
Ye Bogen, Zhang Lei. Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016
Citation: Ye Bogen, Zhang Lei. Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016

《移植器官质量与安全指南(第6版)》解读——感染性疾病传播的风险

doi: 10.3969/j.issn.1674-7445.2020.02.016
基金项目: 

国家自然科学基金青年基金 81702836

详细信息
    作者简介:

    叶伯根,男,1983年生,博士,主治医师,研究方向为肝移植基础与临床研究,Email:yebogen@126.com

    通讯作者:

    张雷,男,1973年生,博士,副主任医师,硕士生导师,研究方向为肾移植基础临床与研究,Email:zl3514@139.com

  • 中图分类号: R617, R63

Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission

More Information
  • 摘要: 供者感染可通过移植物传播给受者,导致并发症甚至死亡。供者来源性感染是实体器官移植术后早期感染的重要原因。2016年欧盟编写的《移植器官质量与安全指南(第6版)》的中文译本已正式出版。其中第8章“感染性疾病传播的风险”,在无症状供者感染风险的病史和行为史、各类感染的基本筛查要点、各类病原体的传播风险以及防治策略等方面进行了详细阐述。本文对该章节进行解读。

     

  • [1] 中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所.中国实体器官移植供者来源感染防控专家共识(2018版)[J].中华器官移植杂志, 2018, 39(1):41-52.DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Hospital Infection Control of Chinese Preventive Medicine Association, Antibiotics Institute of Huashan Hospital of Fudan University. Expert consensus on prevention and control of solid organ transplant donor source infection in China (2018 edition)[J]. Chin J Organ Transplant, 2018, 39(1):41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
    [2] European Committee (Partial Agreement) on Organ Transplantation (CD-P-TO) EDQM.移植器官质量与安全指南(原书第6版)[M].张雷, 译.北京: 科学出版社, 2019.
    [3] THWAITES GE, DAY NP. Approach to fever in the returning traveler[J]. N Engl J Med, 2017, 376(6):548-560. DOI: 10.1056/NEJMra1508435.
    [4] ANNAMBHOTLA PD, GURBAXANI BM, KUEHNERT MJ, et al. A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors[J]. Transpl Infect Dis, 2017, 19(2). DOI: 10.1111/tid.12676.
    [5] SURYAPRASAD A, BASAVARAJU SV, HOCEVAR SN, et al. Transmission of hepatitis C virus from organ donors despite nucleic acid test screening[J]. Am J Transplant, 2015, 15(7):1827-1835. DOI: 10.1111/ajt.13283.
    [6] FOSTER MA, WEIL LM, JIN S, et al. Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation[J]. Emerg Infect Dis, 2017, 23(4):590-596. DOI: 10.3201/eid2304.161532.
    [7] GAMBATO M, PÉREZ-DEL-PULGAR S, HEDSKOG C, et al. Hepatitis C virus RNA persists in liver explants of most patients awaiting liver transplantation treated with an interferon-free regimen[J]. Gastroenterology, 2016, 151(4):633-636. DOI: 10.1053/j.gastro.2016.06.025.
    [8] LEVITSKY J, FORMICA RN, BLOOM RD, et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation[J]. Am J Transplant, 2017, 17(11):2790-2802. DOI: 10.1111/ajt.14381.
    [9] GOLDBERG DS, ABT PL, BLUMBERG EA, et al. Trial of transplantation of HCV-infected kidneys into uninfected recipients[J]. N Engl J Med, 2017, 376(24):2394-2395. DOI: 10.1056/NEJMc1705221.
    [10] NOWAK KM, WITZKE O, SOTIROPOULOS GC, et al. Transplantation of renal allografs from organ donors reactive for HCV antibodies to HCV-negative recipients: safety and clinical outcome[J]. Kidney Int Rep, 2016, 2(1):53-59. DOI: 10.1016/j.ekir.2016.09.058.
    [11] KHAN B, SINGER LG, LILLY LB, et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient[J]. Am J Transplant, 2017, 17(4):1129-1131. DOI: 10.1111/ajt.14137.
    [12] European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016[J]. J Hepatol, 2017, 66(1):153-194. DOI: 10.1016/j.jhep.2016.09.001.
    [13] HÉZODE C. Pan-genotypic treatment regimens for hepatitis C virus: advantages and disadvantages in high-and low-income regions[J]. J Viral Hepat, 2017, 24(2):92-101. DOI: 10.1111/jvh.12635.
    [14] POURBAIX A, QUALI N, SOUSSAN P, et al. Evidence of hepatitis E virus transmission by renal graft[J]. Transpl Infect Dis, 2017, 19(1). DOI: 10.1111/tid.12624.
    [15] MULLER E, BARDAY Z, MENDELSON M, et al. HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years[J]. N Engl J Med, 2015, 372(7):613-620. DOI: 10.1056/NEJMoa1408896.
    [16] CALMY A, VAN DELDEN C, GIOSTRA E, et al. HIV-positive-to-HIV-positive liver transplantation[J]. Am J Transplant, 2016, 16(8):2473-2478. DOI: 10.1111/ajt.13824.
    [17] HATHORN E, SMIT E, ELSHARKAWY AM, et al. HIV-positive-to-HIV-positive liver transplantation[J]. N Engl J Med, 2016, 375(18):1807-1809. DOI: 10.1056/NEJMc1603850.
    [18] MALANI P. HIV and transplantation: new reasons for HOPE[J]. JAMA, 2016, 316(2):136-138. DOI: 10.1001/jama.2016.8158.
    [19] AMBARAGHASSI G, CARDINAL H, CORSILLI D, et al. First Canadian case report of kidney transplantation from an HIV-positive donor to an HIV-positive recipient[J]. Can J Kidney Health Dis, 2017, 4:2054358117695792. DOI: 10.1177/2054358117695792.
    [20] GROSSI PA. Risk assessment for HIV+ organ donors: is the CD4 T cell count a marker of increased risk of transmissible diseases?[J]. Transplantation, 2017, 101(4):684-685. DOI: 10.1097/TP.0000000000001626.
    [21] COOK LB, MELAMED A, DEMONTIS MA, et al. Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients[J]. Retrovirology, 2016, 13:3. DOI: 10.1186/s12977-015-0236-7.
    [22] GUPTA RK, GUPTA G, CHORASIYA VK, et al. Dengue virus transmission from living donor to recipient in liver transplantation: a case report[J]. J Clin Exp Hepatol, 2016, 6(1):59-61. DOI: 10.1016/j.jceh.2016.01.005.
    [23] NOGUEIRA ML, ESTOFOLETE CF, TERZIAN AC, et al. Zika virus infection and solid organ transplantation: a new challenge[J]. Am J Transplant, 2017, 17(3):791-795. DOI: 10.1111/ajt.14047.
    [24] BARJAS-CASTRO ML, ANGERAMI RN, CUNHA MS, et al. Probable transfusion-transmitted Zika virus in Brazil[J]. Transfusion, 2016, 56(7):1684-1688. DOI: 10.1111/trf.13681.
    [25] KAUL DR, MEHTA AK, WOLFE CR, et al. Ebola virus disease: implications for solid organ transplantation[J]. Am J Transplant, 2015, 15(1):5-6. DOI: 10.1111/ajt.13093.
    [26] VAN DUIN D, BONOMO RA. Cefazidime/avibactam and cefolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations[J]. Clin Infect Dis, 2016, 63(2):234-241. DOI: 10.1093/cid/ciw243.
    [27] FERNANDEZ R, RATLIFF A, CRABB D, et al. Ureaplasma transmitted from donor lungs is pathogenic after lung transplantation[J]. Ann Thorac Surg, 2017, 103(2):670-671. DOI: 10.1016/j.athoracsur.2016.09.026.
    [28] WANG X, GREENWOOD-QUAINTANCE KE, KARAU MJ, et al. Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(3):517-522. DOI: 10.1007/s10096-016-2827-1.
    [29] WANG X, KARAU MJ, GREENWOOD-QUAINTANCE KE, et al. Ureaplasma urealyticum causes hyperammonemia in an experimental immunocompromised murine model[J]. PLoS One, 2016, 11(8):e0161214. DOI: 10.1371/journal.pone.0161214.
    [30] BHARAT A, CUNNINGHAM SA, SCOTT BUDINGER GR, et al. Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans[J]. Sci Transl Med, 2015, 7(284):284re3. DOI: 10.1126/scitranslmed.aaa8419.
    [31] TROTTER PE, ROBB M, HULME W, et al. Transplantation of organs from deceased donors with meningitis and encephalitis: a UK registry analysis[J]. Transpl Infect Dis, 2016, 18(6):862-871. DOI: 10.1111/tid.12621.
  • 加载中
计量
  • 文章访问数:  123
  • HTML全文浏览量:  19
  • PDF下载量:  27
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-11-01
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2020-03-15

目录

    /

    返回文章
    返回